Skip to content

Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients

Combined Behavioral and Pharmacological Intervention for Cardiovascular Risk Reduction in Diabetic Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00357955
Enrollment
118
Registered
2006-07-28
Start date
2004-08-31
Completion date
2008-05-31
Last updated
2024-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Arteriosclerosis, Diabetes, Dyslipidemia, Hypertension

Brief summary

The purpose of this research is to study whether a multidisciplinary education in Diabetes and intervention for cardiac risk reduction in a group setting to modify patient behavior and adjust medications can achieve diabetes guideline goals for glycemia, blood pressure and lipid control.

Interventions

BEHAVIORALBehavioral counseling and peer support

Multidisciplinary education and diabetes intervention for cardiac risk reduction - pharmacist led group intervention

interactive lectures with hands-on learning

BEHAVIORALRole modeling

learning from peers with similar disease and problems

provided by clinical pharmacists following pre-established algorithms

Sponsors

Rhode Island Foundation
CollaboratorOTHER
Providence VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All diabetic veterans with a Hb-A1c between 7.0- 9.0 % within the last 6 months will be eligible for the study

Exclusion criteria

* Patients without an Hb-A1c checked within the last 6 months. * Patients who are unable to attend the group sessions, either because of lack of transportation, psychiatric instability (suicidal, psychotic), or organic brain injury that preclude them from diabetes self-care.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm Hg4 monthsThe major outcome was the percentage of participants who attain the target goals for A1C, blood pressure,and ldl cholesterol lipids set by the American Diabetes Association guidelines, defined as A1C \<7%, SBP \<130 mm Hg, diastolic blood pressure (DBP) \<80 mm Hg, and LDL cholesterol \<100 mg/dL (2.6 mmol/L).

Countries

United States

Participant flow

Recruitment details

Eligible patients were identified by a combination of the review of the VA Medical Center's electronic medical record system and referral by primary care providers. Recruitment started July 2004 and enrollment was completed by May 2007.

Pre-assignment details

Once eligibility confirmed and consent signed, participants were randomized. There were no wash-out or run-in period.

Participants by arm

ArmCount
MEDIC
Multidisciplinary education and diabetes intervention for cardiac risk reduction Pharmacologic case management : provided by clinical pharmacists following pre-established algorithms Behavioral counseling and peer support : Multidisciplinary education and diabetes intervention for cardiac risk reduction - pharmacist led group intervention Role modeling : learning from peers with similar disease and problems Interactive Education : interactive lectures with hands-on learning
58
Usual Care
usual care
51
Total109

Baseline characteristics

CharacteristicUsual CareMEDICTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
31 Participants19 Participants50 Participants
Age, Categorical
Between 18 and 65 years
20 Participants39 Participants59 Participants
Age, Continuous66.8 years
STANDARD_DEVIATION 10.2
62 years
STANDARD_DEVIATION 10.3
64.4 years
STANDARD_DEVIATION 10.5
Region of Enrollment
United States
51 participants58 participants109 participants
Sex: Female, Male
Female
0 Participants5 Participants5 Participants
Sex: Female, Male
Male
51 Participants53 Participants104 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
11 / 582 / 51
serious
Total, serious adverse events
0 / 581 / 51

Outcome results

Primary

Percentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm Hg

The major outcome was the percentage of participants who attain the target goals for A1C, blood pressure,and ldl cholesterol lipids set by the American Diabetes Association guidelines, defined as A1C \<7%, SBP \<130 mm Hg, diastolic blood pressure (DBP) \<80 mm Hg, and LDL cholesterol \<100 mg/dL (2.6 mmol/L).

Time frame: 4 months

ArmMeasureGroupValue (NUMBER)
MEDICPercentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm HgA1c <7%40.4 percentage
MEDICPercentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm HgSystolic Blood Pressure<130mmHg65.5 percentage
MEDICPercentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm HgDiastolic Blood Pressure<80mmHg87.9 percentage
MEDICPercentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm HgLDL Cholesterol <100mg/dL77.2 percentage
Usual CarePercentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm HgLDL Cholesterol <100mg/dL77.5 percentage
Usual CarePercentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm HgA1c <7%21.6 percentage
Usual CarePercentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm HgDiastolic Blood Pressure<80mmHg68.6 percentage
Usual CarePercentage of Participans With A1c<7%, LDL Cholesterol <100mg/dL, Systolic Blood Pressure <130mm Hg and Diastolic Blood Pressure <80 mm HgSystolic Blood Pressure<130mmHg39.9 percentage

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026